新表位检测识别全身炎症与脓毒症中的细胞外基质周转:一项探索性研究
该探索性研究对10名健康男性志愿者静脉给予2 ng/kg大肠埃希菌来源脂多糖(LPS)诱导全身炎症,于T0及T1h、3h、6h、24h采集血浆;另纳入43例脓毒症休克患者于ICU入住第1天采集血浆。采用ELISA检测细胞外基质(ECM)降解新表位(C1M、C3M、C4Ma3、C6M、ELP-3、X-FIB)及合成新表位(PRO-C3、PRO-C4、PRO-C6)。结果显示LPS后24小时除ELP-3外所有ECM周转新表位均较基线升高;脓毒症休克患者所有ECM新表位均高于健康对照;未存活者(N=7)的C6M、ELP-3和X-FIB高于恢复者(N=36)。提示ECM周转在全身炎症模型中被诱导,并在脓毒症休克患者中观察到,可能为脓毒症器官衰竭机制提供线索。
要点
- 健康志愿者静脉给予2 ng/kg LPS后24小时,除ELP-3外所有ECM周转新表位均较基线升高。
- 脓毒症休克患者(N=43)所有ECM新表位浓度均高于健康对照。
- 未存活脓毒症休克患者(N=7)的C6M、ELP-3和X-FIB浓度高于恢复者(N=36)。
- ECM周转在全身炎症模型中被诱导,并在脓毒症休克患者中观察到。
适用人群与场景
- 健康男性志愿者10名,接受2 ng/kg大肠埃希菌来源脂多糖(LPS)静脉注射以诱导全身炎症。
- 脓毒症休克患者43例,于ICU入住第1天采集血浆。
研究设计与关键结果
- 探索性研究:10名健康男性志愿者静脉给予2 ng/kg LPS,于T0及T1h、3h、6h、24h采集血浆;43例脓毒症休克患者于ICU入住第1天采集血浆;ELISA检测ECM降解新表位(C1M、C3M、C4Ma3、C6M、ELP-3、X-FIB)及合成新表位(PRO-C3、PRO-C4、PRO-C6)。
- LPS后24小时,除ELP-3外所有测量的ECM周转新表位均较基线升高。
- 脓毒症休克患者所有测量的ECM新表位浓度均高于健康对照。
- 未存活脓毒症休克患者(N=7)的C6M、ELP-3和X-FIB浓度高于恢复者(N=36)。
证据类型、等级与局限
- 证据类型:探索性研究(人体LPS炎症模型及脓毒症休克患者血浆检测)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is associated with high morbidity and mortality, primarily due to systemic inflammation-induced tissue damage, resulting organ failure, and impaired recovery. Regulated extracellular matrix (ECM) turnover is crucial for maintaining tissue homeostasis in health and in response to disease-related changes in the tissue microenvironment. Conversely, uncontrolled turnover can contribute to tissue damage. Systemic Inflammation is implicated to play a role in the regulation of ECM turnover, but the relationship between the two is largely unclear.
METHODS: We performed an exploratory study in 10 healthy male volunteers who were intravenously challenged with 2 ng/kg lipopolysaccharide (LPS, derived from Escherichia coli) to induce systemic inflammation. Plasma samples were collected before (T0) and after (T 1 h, 3 h, 6 h and 24 h) the LPS challenge. Furthermore, plasma was collected from 43 patients with septic shock on day 1 of ICU admission. Circulating neo-epitopes of extracellular matrix turnover, including ECM degradation neo-epitopes of collagen type I (C1M), type III (C3M), type IV (C4Ma3), and type VI (C6M), elastin (ELP-3) and fibrin (X-FIB), as well as the ECM synthesis neo-epitopes of collagen type III (PRO-C3), collagen type IV (PRO-C4) and collagen type VI (PRO-C6) were measured by ELISA. Patient outcome data were obtained from electronic patient records.
RESULTS: Twenty-four hours after LPS administration, all measured ECM turnover neo-epitopes, except ELP-3, were increased compared to baseline levels. In septic shock patients, concentrations of all measured ECM neo-epitopes were higher compared to healthy controls. In addition, concentrations of C6M, ELP-3 and X-FIB were higher in patients with septic shock who ultimately did not survive (N = 7) compared to those who recovered (N = 36).
CONCLUSION: ECM turnover is induced in a model of systemic inflammation in healthy volunteers and was observed in patients with septic shock. Understanding interactions between systemic inflammation and ECM turnover may provide further insight into mechanisms underlying acute and persistent organ failure in sepsis.
参考来源
- Fan Y, Moser J, van Meurs M, et al. Neo-epitope detection identifies extracellular matrix turnover in systemic inflammation and sepsis: an exploratory study. Crit Care. 2024. PMID: 38609959. doi:10.1186/s13054-024-04904-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。